Search For "inhibitors"
HemeNext 2025: India's Premier Hematology Conference Unveils the Future of
Updated : 6 months, 2 weeks ago IST
Gurgaon (Haryana) [India], November 25: HemeNext 2025, held at The Westin Hotel, Gurgaon on the 22nd and 23rd of November, welcomed nearly 300 delegates from across the country, making it one of India's most anticipated gatherings in the field of hematology. Conceptualised and led by Dr Rahu
Read More
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for In
Updated : 8 months ago IST
New Delhi [India], October 9: MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is the first to launch the revolutionary JAK inhibitor molecules Tofacitinib (Tofadoz) and Upadacitinib (Upadoz) in India.
Read More
Mechanism behind life-threatening cancer drug side-effect revealed
Updated : 8 months, 1 week ago IST
New research has found immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint inhibitors.
Read More
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered De
Updated : 1 year, 4 months ago IST
London [UK]/ Munich [Germany]/ New Delhi [India], February 4: Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options. It integrates a 360° tu
Read More
Long-term metastatic melanoma survival dramatically improves on immunother
Updated : 8 months, 1 week ago IST
Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre i
Read More
Long-term metastatic melanoma survival significantly improves with treatme
Updated : 1 year, 8 months ago IST
According to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and their colleagues, long-term data from a landmark international trial show that approximately half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibit
Read More
Study finds how certain diabetes medications might prevent dementia
Updated : 1 year, 9 months ago IST
According to a study published, sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes may prevent dementia, with higher advantages with prolonged treatment.
Read More
Researchers find ways to reduce side effects of breast, ovarian cancer tre
Updated : 8 months, 1 week ago IST
Certain anti-cancer medications also target healthy cells in addition to malignant cells. Their use may become restricted if their effects on the latter are excessively powerful. The mechanism of action of PARP inhibitors, which are specifically used for treating breast and ovarian cancer in
Read More
Kidney stone risk is lowered by a class of diabetes medications: Study
Updated : 8 months, 1 week ago IST
Researchers at Mass General Brigham discovered that using sodium-glucose contratransporter 2 (SGLT2) inhibitors was associated with a decreased chance of acquiring kidney stones. Their findings were published in JAMA Internal Medicine.
Read More
Scientists created new antibody to combat breast cancer
Updated : 8 months, 1 week ago IST
Professor Nicholas Tonks' laboratory identified an antibody that can suppress an enzyme that may aid in the spread of some breast tumours. With more research, the antibody may be able to give a feasible therapeutic treatment for the same breast cancers.
Read More
Sotagliflozin provides kidney, heart-related benefits to patients
Updated : 8 months, 1 week ago IST
Patients with and without diabetes can benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are drugs that, among other things, reduce blood sugar levels and improve heart and kidney function.
Read More
Researchers develop new antibody against breast cancers
Updated : 2 years, 7 months ago IST
An antibody developed in the lab of Cold Spring Harbour Laboratory Professor Nicholas Tonks can inhibit an enzyme that may aid in the spread of some breast tumours. With additional research, the antibody could provide a viable therapeutic treatment for the same breast tumours.
Read More